Covered recipient · General Payments record
MAHMOUD ELSAYED
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2019–2024
$2,375.85
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,488.38 | 5 |
| Food and Beverage | $704.78 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOTRONIK INC. | $1,420.88 | 15 |
| Medtronic, Inc. | $738.44 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $33.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BIOTRONIK INC. | $59.73 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806777 | CMS |
| BIOTRONIK INC. | $298.96 | 02/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1145806701 | CMS |
| BIOTRONIK INC. | $11.54 | 02/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1145806657 | CMS |
| BIOTRONIK INC. | $99.64 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806659 | CMS |
| BIOTRONIK INC. | $5.51 | 02/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806661 | CMS |
| BIOTRONIK INC. | $3.34 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806663 | CMS |
| BIOTRONIK INC. | $44.06 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806711 | CMS |
| BIOTRONIK INC. | $439.44 | 10/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1145806719 | CMS |
| BIOTRONIK INC. | $114.26 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806727 | CMS |
| BIOTRONIK INC. | $63.82 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806735 | CMS |
| BIOTRONIK INC. | $83.68 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806743 | CMS |
| BIOTRONIK INC. | $57.60 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806751 | CMS |
| BIOTRONIK INC. | $66.29 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806759 | CMS |
| BIOTRONIK INC. | $45.67 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806765 | CMS |
| BIOTRONIK INC. | $27.34 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145806771 | CMS |
| Boston Scientific Corporation | $33.84 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092604168 | CMS |
| Medtronic, Inc. | $677.65 | 02/06/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119309992 | CMS |
| Medtronic, Inc. | $60.79 | 03/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1119309994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.